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Abstract: Abstract
Objective: Behavioral interventions are recommended as ADHD treatments. However,
a recent meta-analysis found no effects on core ADHD symptoms when raters were
probably blind to treatment allocation. Here, this analysis is extended to a broader
range of child and parent outcomes.
Method: A systematic search in Pubmed, Ovid, Web of Knowledge, ERIC, and
CINAHAL  databases  (up to February 5th, 2013) identified published randomized
controlled trials measuring a range of patient and parent outcomes for children and
adolescents diagnosed with ADHD (or who met validated cut-offs on rating scales).
Results: Thirty two of 2057 non-duplicate screened records were analyzed. For
assessments made by individuals closest to the treatment setting (usually unblinded)
there were significant improvements in parenting quality (standardized mean difference
(SMDpositive parenting = 0.68; SMDnegative parenting = 0.57) and parenting self-
concept (SMD=0.37) as well as child ADHD (SMD = 0.35), conduct problems (SMD =
0.26), social skills (SMD = 0.47) and academic performance (SMD= 0.28). With
probably blinded assessments significant effects persisted for parenting (SMDpositive
parenting = 0.63 and SMDnegative parenting=0.43) and conduct problems (SMD =
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation0.31).
Conclusions:  In contrast to the lack of blinded evidence of ADHD symptom reduction,
behavioral interventions have positive effects on a range of other outcomes when used
with ADHD patients. There is blinded evidence that they improve parenting and reduce
childhood conduct problems. These effects may also feed through into a more positive
parenting self-concept but not improved parent mental wellbeing.
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Abstract 
 
Objective: Behavioral interventions are recommended as ADHD treatments. However, a 
recent meta-analysis found no effects on core ADHD symptoms when raters were probably 
blind to treatment allocation. Here, this analysis is extended to a broader range of child and 
parent outcomes. 
Method: A systematic search in Pubmed, Ovid, Web of Knowledge, ERIC, and CINAHAL  
databases  (up to February 5
th, 2013) identified published randomized controlled trials 
measuring a range of patient and parent outcomes for children and adolescents diagnosed 
with ADHD (or who met validated cut-offs on rating scales). 
Results: Thirty two of 2057 non-duplicate screened records were analyzed. For 
assessments made by individuals closest to the treatment setting (usually unblinded) there 
were significant improvements in parenting quality (standardized mean difference(SMD)
positive 
parenting = 0.68; SMD
negative parenting = 0.57) and parenting self-concept (SMD=0.37) as well as 
child ADHD (SMD = 0.35), conduct problems (SMD = 0.26), social skills (SMD = 0.47) and 
academic performance (SMD= 0.28). With probably blinded assessments significant effects 
persisted for parenting (SMD
positive parenting = 0.63 and SMD
negative parenting=0.43) and conduct 
problems (SMD = 0.31). 
Conclusions:  In contrast to the lack of blinded evidence of ADHD symptom reduction, 
behavioral interventions have positive effects on a range of other outcomes when used with 
ADHD patients. There is blinded evidence that they improve parenting and reduce childhood 
conduct problems. These effects may also feed through into a more positive parenting self-
concept but not improved parent mental wellbeing.   
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Introduction 
 
Attention-Deficit Hyperactivity Disorder (ADHD) is characterised by age inappropriate, 
persistent, and pervasive inattention and/or over-activity/impulsiveness which impairs daily 
functioning
1 and is associated with substantial long term burden on patients, families and 
health and educational services
2,3. Multi-modal treatment approaches are recommended
4. 
Medication is typically used as the first line intervention, especially for severe cases
5. 
Despite robust evidence of medium-term symptom control
6, medication has a number of 
limitations. A proportion of patients show partial or no response
6. Long-term effectiveness 
remains to be established
7,8. Important aspects of functioning may not improve (e.g., 
academic achievement
9). Adverse effects on sleep, appetite and growth, though rarely 
serious and generally manageable, are common and may not be well tolerated
10. Treatment 
compliance can be low especially during adolescence
11. Finally, parents and clinicians can 
have reservations about medication use
12 and may prefer non-pharmacological 
approaches
13 .  
Interventions employing behavioral techniques are also recommended and 
commonly used as ADHD treatments
14. Systematic reviews of treatment trials have provided 
evidence to support their efficacy
15,16,17. However, these reviews can be difficult to interpret 
as they sometimes include non-randomized controlled trials (RCT’s), mix individuals with 
and without ADHD and have not always drawn clear boundaries between ADHD-specific 
and other outcomes. Furthermore, outcome assessment is often made unblinded by 
individuals taking an active part in the intervention (e.g., parents receiving parent training), 
which is likely to inflate efficacy estimates
18.  Sonuga-Barke et al. published a meta-analysis 
of randomized controlled trials (RCT) of behavioral interventions
19. Stringent inclusion and 
exclusion criteria addressed some of the limitations of previous meta-analyses. There was a 
moderate, statistically significant positive effect on ADHD core symptoms for assessments 
made by individuals most proximal to the therapeutic setting - typically unblinded parent 
ratings. However, these effects were not corroborated by probably blinded measures made 
either by observers or raters unaware of treatment allocation where the effect size dropped 
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to near zero and became non-significant. A similar, though less marked reduction, was found 
for neuro-feedback and cognitive training. There are a number of possible explanations for 
these findings. First, that unblinded raters are biased and overestimate treatment effects
20. 
Second, that interventions increase either parental tolerance for ADHD or their ability to cope 
with its negative impact rather than reducing symptom levels
19. Third, that probably blinded 
measures were less valid than most proximal measures
21. Finally, that intervention effects 
did not generalize from the therapeutic setting (e.g., the home) to other settings (e.g., 
school)
22.  The authors concluded that more evidence from studies with blinded 
assessments is required before behavioral interventions can be supported as treatments for 
core ADHD symptoms.  
The limited effects of behavioral approaches on blinded core ADHD measures may 
be explicable if one considers the treatment models upon which many are based. For 
instance, although most treatments in the trials included in the Sonuga-Barke et al.
19, meta-
analysis were implemented to target ADHD symptoms they were initially developed, and 
have been used extensively, for children with oppositional and conduct problems
23, 24, 25. For 
many of these the rationale is that children’s challenging behavior develops because of 
coercive interactional cycles which, over-time, co-reinforce non-compliant and oppositional 
behaviors in the child and negative and inappropriate responses from significant adults 
(usually the parent but also potentially teachers and other care givers) 
26. During intervention 
the adult is taught to apply behavior modification techniques to reinforce appropriate and 
extinguish inappropriate child behaviors, enhance effective and enjoyable adult-child 
interactions
27 and so transform negative into positive interactional cycles. Such interventions, 
it could be argued, are unlikely to be effective as treatments for core ADHD symptoms 
because ADHD does not emerge via a similar environmentally mediated route as conduct 
problems and is therefore less likely to respond to the modification of environmental 
contingencies
28.  
However, the value of behavioral interventions does not rest exclusively on their 
potential effects on ADHD symptoms. Patients with ADHD often have conduct problems
29 
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and other comorbidities
30 as well as poor social and organisational skills and low academic 
achievement. Their parents can suffer from poor parenting self-concept and mental health 
problems
31. These associated features of the disorder are important treatment targets in and 
of themselves as each is associated with substantial burden to the child, their family and 
society via the criminal justice, social and health systems
22, 
32. Behavioral interventions may 
have an important role in treating these problems whether or not they reduce core ADHD 
symptoms. Indeed behavioral treatments used with patients with ADHD have targeted such 
ADHD-related but non-specific aspects of impairment rather than ADHD symptoms 
themselves (e.g., social skills 
33; organisational skills 
34; academic achievement 
35).  
In this paper we build on the previous meta-analysis
19 to address this broader impact 
of behavioral interventions for children with ADHD. We address three related questions. 
First, given that most, though not all, interventions are implemented via changes in the 
behaviour of responsible adults (typically either parents or teachers), do behavioral 
interventions improve adult responses to children with ADHD? Second, do they improve the 
sense of efficacy and competence and reduce the mental health problems of adults working 
with children with ADHD? Third, do they reduce levels of child oppositional behaviour and 
other comorbidities and other aspects of impairment such as social skills and academic 
performance? To address these questions most proximal and probably blinded assessments 
were once again contrasted.  
Methods  
Please see the registered protocol CRD42011001393 at (link deleted to blind the identity of 
the authors) for more details.  
Inclusion Criteria: Only published peer reviewed RCTs were included although we also 
acknowledge that many well-designed studies using single-subject research designs 
examining the effects of behavioral interventions have been published. Following the 
recommendation of the Cochrane group we limited our search to published trials to ensure a 
level of methodological adequacy and rigour among included trials and to avoid the 
inevitable problems with securing access to a full set of unpublished trials and the bias that 
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this would introduce 
36. Participants needed to be between ages three and 18 years and 
have an ADHD diagnosis (any subtype) or have met accepted cut offs on validated ADHD 
rating scales. Trials just involving rare comorbid disorders (e.g., fragile X syndrome) were 
excluded. Acceptable control conditions were “treatment as usual”, “wait list” or “active” 
controls. “Treatment as usual” could include medication, but trials were excluded if the 
behavioral intervention was an adjunct to medication or if both pharmacological and 
behavioral interventions were combined into one therapeutic arm as part of study design.  
For the present extended review, trials could be included despite not having an ADHD-
related outcome (as required in the original protocol).  
Search Strategy 
The search was updated February 5
th, 2013.  SC and MF blindly conducted and cross-
checked the updated search using the same databases, search strategy and search terms 
as used previously
19 (see protocol). The searches were conducted for records included from 
the inception of the data-bases. Behavioral interventions were defined as those interventions 
directed at changing behaviors (increasing desired and decreasing undesired 
behaviors).They encompass classical contingency management, behaviour therapy (mainly 
through mediators such as parents or teachers) and cognitive behaviour therapy (such as 
verbal self-instruction, problem solving strategies or social skills training). The treatment 
search terms covered a wide variety of intervention types with the aim of including trials 
involving any form of behaviorally-based therapies, implemented in any setting (home or 
school) either indirectly via an adult or directly to the child  (see protocol).  
Outcome Measures 
To increase analytical robustness outcome domains were only considered if five or more 
RCTs were available. Outcome measures meeting this criterion were pre- to post-treatment 
changes in positive and negative parenting, parent mental health (e.g., anxiety, depression) 
and parenting self-concept (e.g., sense of competence and efficacy), child ADHD, conduct 
problems (i.e., negative and non-compliant behavior including symptoms of oppositional, 
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defiance and conduct disorders), social skills and academic achievement. There were too 
few RCTs (n < 5) to examine changes in teacher behavior and wellbeing, child impairment, 
internalizing problems, executive/organisational skills or more general measures of family 
functioning. 
Study Selection 
Articles’ titles and abstracts were screened. Final inclusion was based on the full text. Trials 
were blindly double-coded for eligibility. Study quality was assessed by two independent 
raters according to the Jadad criteria
37£ (see table 1). These provide a rating for each trial in 
terms of standard definitions for randomization, blinding and treatment of missing data 
defined by Jadad and colleagues 
37  Jadad scores for blinding were adapted for use with 
multiple outcomes so that studies with at least one blinded outcome yielded a score of 1 on 
this dimension. A score of three or more is regarded as indicating acceptable quality.  Initial 
disagreements (N=4) were resolved by the coders through discussion without recourse to an 
independent arbitrator. 
Data Extraction and Statistical Analysis 
Trial information was entered into RevMan 5.1 (http://ims.cochrane.org/revman)
38. Data 
extraction was independently rated by two authors. The SMD, mean pre- to post-treatment 
change minus the mean pre- to post-treatment control group change divided by the pooled 
pre-test standard deviation with a bias adjustment, was calculated
39. SMDs for trials in each 
domain were combined using the inverse-variance method
36. Given the inherent 
heterogeneity of studies, random-effects models were used. The I
2 statistic was calculated, a 
posteriori, to estimate between-trial SMD heterogeneity. Most proximal and probably blinded 
analyses were both performed for all domains except parent mental health, parenting self-
concept, child social skills and academic outcomes where insufficient trials with probably 
blinded measures were available. Where multiple measures were available for an outcome 
we selected the one most frequently reported across included trials. For the most proximal 
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analysis parent ratings, if available, were used except for teacher-based interventions when 
teacher ratings or direct observations were preferred. Probably blinded assessments were  
£  
made by an individual likely to be blind to allocation. In trials in which more than one such 
measure was available, the best blinded measure was selected. This only affected trials with 
a home-based element where direct observations by an independent researcher and teacher 
ratings were the probably blinded measure. In such cases we selected direct observation 
over teacher ratings. Sensitivity analyses examined: i) the impact of background ADHD 
medication use in trial samples for which at least three trials had less than 30% of 
participants receiving medications (i.e., were no/low medication trials) and; ii) the effects of 
outliers identified using funnel plots within REVMAN 5.1
38.  Meta-regression tested whether 
effect sizes were greater in lower quality trials according to Jadad
37. For one study
34 two 
active treatment arms were suitable for analysis. Parents and Teachers Helping Children 
Organize (PATHKO) and Organizational Skills Treatment (OST) yielded similar results and 
so only one arm, PATHKO, which was considered the more standard behavioral intervention 
was included in the final analysis. For another study
40 outcomes were taken from three 
publications
40, 41, 42. 
 
 Results 
Thirty two studies met entry criteria and had data amenable to analysis. Eight had a Jadad 
study quality rating of three or more
33. Thirty one studies had a parent-based component 
implemented at home. Four had an additional school-based teacher focused element. 
Fourteen included direct intervention with the child. While most employed standard 
behavioral principles and targeted children’s externalizing behaviours (ADHD, ODD, CD), 
some implemented specialised social (n=3), organisational (n=3) or academic skills (n=1). 
Figure 1 reports the trial selection flow chart. Tables 1 and 2 give information about included 
trials, and the measures used in each analysis respectively.  
{figure 1} 
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{tables 1 & 2} 
Do behavioral interventions improve adult responses to children with ADHD? 
No trials measured responses to children with ADHD by adults other than parents (i.e., no 
teachers). Nine trials measured positive parenting. Three most proximal measures were 
parent rated - five were observational. Eight trials had probably blinded measures, all 
observational. For positive parenting, most proximal effects were significant (SMD=0.68; 
95%CI=0.27–1.09; see Figure 2 for forest plots). Effects were similar for probably blinded 
outcomes (SMD=0.63; 95%CI=0.47–0.78). Heterogeneity was significant in both analyses 
(
2most proximal=63.55; I
2 = 87%; p<0.01; 
2probably blinded=40.58; I
2=83%; p<0.01). Effects were 
unaffected by limiting the analyses to no/low medication trials (N=5; SMD
most proximal=1.23; 
95%CI=0.26–2.20; N=4 SMD
probably blinded= .89; 95%CI=0.65–2.13) although heterogeneity 
remained high (
2most proximal = 28.35; I
2 = 89%; p< 0.01; 
2probably blinded= 23.29; I
2=87%; p 
<0.01). Removing outliers reduced effect sizes (N=2 SMD
most proximal=0.32; 95%CI=-0.06–
0.58; N=1 SMD
probably blinded=0.44; 95%CI =0.14–0.75). Heterogeneity was no longer 
significant (
2most proximal =3.46; I
2=0%; p=0.48; 
2probably blinded=0.83; I
2=0%; p=0.66). Fourteen 
trials measured negative parenting. Nine most proximal measures were parent ratings (four 
observations and one speech sample). Eight studies met criteria for probably blinded 
assessments (seven observations and one speech sample). For negative parenting, effects 
were significant for both analyses (SMD
most proximal=0.57; 95%CI=0.37–0.78; SMD
probably blinded 
=0.43; 95%CI=0.24–0.62). Heterogeneity was also significant (
2most proximal=32.7; I
2=60%; 
p<0.01; 
2probably blinded=19.8; I
2=65%; p<0.01). Most proximal effects were unchanged when 
no/low medication trials were analysed (N=7; SMD = 0.57; 95%CI=0.22–.92; 
2=7.81; I
2 = 
49%; p<0.01) but effects became non-significant for probably blinded outcomes (N= 6; 
SMD=0.42; 95%CI=-0.07–0.91;
2=14.25; I
2=72%; p<0.01). When outliers were excluded 
effects remained significant for both outcomes (N=2 SMD
most proximal=0.45; 95%CI=0.31–0.58; 
N=1 SMD
probably blinded=0.36; 95%CI=0.12–0.60). Heterogeneity was reduced for one (
2most 
proximal=15.45; I
2 = 35%; p=.12) but not the other (
2probably blinded=15.03; I
2 = 73%; p<0.01). 
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Do behavioral interventions improve the self-concept and mental health of adults 
working with children with ADHD?   
No trials measured the self-concept and mental health of adults other than parents. Seven 
trials included self-ratings of parental self-concept (six parenting efficacy/sense of 
competence, one parenting self-esteem). There was a small but significant improvement in 
self-concept following treatment (SMD=0.37; 95%CI=0.03–0.70). Heterogeneity was 
significant (
2=19.03; I
2=68%; p<0.01). Effects increased slightly in no/low medication trials 
(n=5; SMD=0.68; 95%CI=0.22–0.92) while heterogeneity reduced substantially (
2=0.99; 
I
2=0%; p=0.61). When outliers were removed (n=1) effects and their heterogeneity were 
reduced to non-significant levels (SMD=0.30; 95%CI=-0.07–0.65; 
2=5.24; I
2=4%; p=0.39). 
Measures of self-rated parent mental health were included in nine studies (seven 
depression/anxiety; two more general well-being). There were no significant effects of 
treatment (SMD=0.09, 95%CI=-0.09–0.23 – no/low medication analysis n=6; SMD=0.09; 
95%CI=-0.19–0.37; p=0.13; 
2=5,63; I
2=47%; p<0.01). No outliers were identified. 
{figure 2} 
 
Do behavioural interventions reduce child psychopathology and improve 
functioning?  
Nineteen studies had most proximal ADHD measures (four in addition to the trials included 
in Sonuga-Barke et al. 
21). The treatment effect was significant (SMD=0.35; 95%CI=0.19–
0.50). Heterogeneity was significant (
2=32.63; I
2=45%; p< 0.05). Restricting the analysis to 
no/low medication enhanced the effect (n=11; SMD= 0.50; 95%CI=0.24–0.76) but 
heterogeneity remained significant (
2
 =20.33; I
2=51%; p<0.05). Effects were reduced when 
outliers (n=3) were removed but remained significant (SMD=0.23; 95%CI=0.12–0.35). 
Heterogeneity was no longer significant (
2=16.86; I
2=23%; p=0.21). None of the trials added 
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since Sonuga-Barke et al.
19 had a probably blinded measure so the prior finding of no 
treatment effect for ADHD remained unchanged (Overall SMD=0.02, 95% CI=–0.30-0.34).   
Fifteen trials had most proximal measures of conduct problems (ten parent, and three 
teacher ratings, and two clinic observations). Eight trials had probably blinded measures 
(one teacher and seven observational ratings). Both most proximal and probably blinded 
effects were significant (SMD= 0.26
most proximal; 95%CI=0.14–0.37; SMD=0.31
probably blinded; 
95%CI=-0.05–0.57). Heterogeneity was significant for most proximal (
2
=25.87; I
2 = 46%; 
p=0.03) but not for probably blinded (
2
= 14.28; I
2=51%; p=0.05). Low/no medication studies 
gave significant effects for both analyses (n=7; SMD
most proximal=0.54; 95%CI=0.32–0.76; N=6; 
SMD
probably blinded=0.27; 95%CI=0.02–0.51). Heterogeneity was not significant for either of 
these analysis (
2most proximal= 5.96; I
2=37%; p=0.43; 
2probably blinded= 3.77; I
2=0%; p=0.44). Most 
proximal effects remained significant when outliers (n=2) were removed (SMD=0.26; 
95%CI=0.12–0.46; 
2= 14.16; I
2=22% p=0.22). There were no probably blinded outliers.  
Nine trials included most proximal social skills outcomes (four parent and five teacher 
ratings). Four of these included a core specialised social skills training component. The 
effect was significant (SMD=0.47; 95%CI=0.15–0.78) as was heterogeneity (
2=22.98; 
I
2=65%; p<0.01). Restricting the analysis to the no/low medication studies increased 
heterogeneity (N=5; 
2=22.08; I
2=86%; p<0.01) so that while the effect size increased it was 
no longer significant (SMD = 0.67; 95%CI=-0.20–1.55). When outliers (n=1) were removed 
the effect remained (SMD=0.30; 95%CI=0.07-0.52) and heterogeneity was non-significant 
(
2=4.04; I
2=0% p=0.54). 
Academic achievement was measured in nine trials (six parent or teacher 
questionnaire-based measures and three objective assessments). Seven studies had a 
specialised component to specially target this aspect of impairment. Most proximal effects 
were significant and heterogeneity was non-significant (SMD=0.28; 95%CI=0.06–0.50; 
2 
=14.55; I
2=45%; p=0.07) and persisted when outliers (N=2) were removed (SMD=0.16; 
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95%CI=0.01–0.31) and heterogeneity was non-significant (
2=7.95; I
2=37%; p=0.16). There 
were insufficient no/low medication studies to conduct a sensitivity analysis. 
{figure 3} 
There was no association between larger effect sizes and lower Jadad ratings. In 
fact, for most proximal ADHD (t = 2.52; p = 0.02), higher quality trials yielded larger effects. 
Meta-regression did reveal larger effect sizes in trials with younger children for most 
proximal positive parenting (t=-2.63; p = 0.03) most proximal ADHD (t = -2.09; P = 0.05 and 
most proximal conduct problems (t = -2.46; P = 0.03). 
 
Discussion 
The current meta-analyses found blinded evidence that behavioral interventions used to 
treat children and adolescents with ADHD had beneficial effects on important aspects of 
child and parent functioning. This contrasts with the lack of blinded evidence relating to 
ADHD symptoms reported in Sonuga-Barke et al.
19. Specifically, in this analysis behavioral 
interventions improved parenting, reducing negative and increasing positive parenting, and 
reduced children’s comorbid conduct problems.  
Although improving parent functioning was rarely their primary therapeutic goal 
nearly all behavioral interventions included parent training as a core therapeutic mechanism. 
Positive effects on these outcomes are therefore both expectable and, in some ways, a 
necessary condition for subsequent impacts on children’s behavior. Given the need to pool 
across very diverse and often rather general parenting assessments a fine-grained analysis 
of these effects was not possible. For instance, positive parenting analyses pooled studies 
with general assessments of overall increases in positive behaviours/strategies (e.g., praise, 
encouragement
61) together with measures of their appropriate use
25 according to therapeutic 
models. This is important as, according to most models
28, simply increasing levels of positive 
parenting may not be sufficient to produce positive changes in children’s behaviour. 
Objective effects on parenting were reflected in improved parenting self-concept - an 
empowering effect important in the process of breaking negative parent-child interaction 
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cycles
31. Increased parenting confidence could come from working with experienced 
therapists who validate parents’ approaches and/or implementing behavioral strategies and 
seeing their positive effects. It may also be an effect of psycho-education that emphasizes 
the power parents have to influence developmental outcomes
67.  Given these parenting-
specific positive effects it was perhaps surprising that no beneficial effects were seen on 
parent mental health more generally. It would seem that the high levels of mental health 
problems that often affect parents of children with ADHD are not solely the result of issues 
around parenting morale but rather reflect a more deep-seated, pervasive psychological 
aspect perhaps reflecting shared genetic risk for mental health problems within families
68, 69. 
There was also blinded evidence that behavioral interventions reduced conduct problems in 
children with ADHD; benefits of behavioral interventions for children seen with conduct 
disorder extend to those with a full ADHD diagnosis
25. Given the limited number of studies 
with probably blinded measures and the fact that few had objective measures of child 
behavior measured at both home and school we were unable to assess the generalisation of 
child effects across settings.  According to most proximal measures children’s academic 
performance and social skills were also improved – an effect that is perhaps not surprising 
as  trials included in these analyses often specifically targeted these aspects of impairment 
with specialised packages.  If these effects could be corroborated with blinded ratings this 
would be encouraging given the inconsistent evidence regarding the effects of medication on 
these outcomes
44, 55. 
   When interpreting the current analysis, it is important to take a number of factors into 
account; all meta-analyses are constrained by the quality and diversity of the studies 
available for inclusion. First, for nearly all of the analyses there was significant SMD 
heterogeneity between studies that may reflect the variety of intervention and outcome types 
analysed. In most, though not all cases, removing outliers identified using funnel plots 
reduced this heterogeneity while leaving treatment effects significant. Second, we could not 
establish how many parents had definite parenting or mental health problems, or how many 
children had clinical levels of conduct problems. As participants were specifically selected for 
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ADHD in childhood, it is likely that substantial numbers of individuals were unaffected by 
these additional problems. As a consequence effect sizes seen for these outcomes, given 
the smaller room for improvement, are likely to be an under-estimate of the true effects of 
behavioral interventions. Third, Sonuga-Barke et al
19 raised questions about the status of the 
probably blinded measures as valid outcomes. This is because they were often based on 
relatively small snap-shots of behavior or a rating by a teacher who may not know the child 
well. However, in the current study these measures proved to be sensitive to treatment-
related change. Fourth, our evaluation did not explore the impact on long-term outcomes 
where one might predict a more robust impact of behavioral interventions. Fifth, while we 
established that parenting improved on rather artificial trial-based assessments these may 
not have been able to capture improvements in everyday life situations. Sixth, there were 
insufficient studies to explore whether interventions specifically tailored for ADHD
64 were 
more effective than parenting interventions designed to treat more general childhood 
behaviour problems or other aspects of impairment (social and academic skills). Seventh, 
the pool of trials meeting inclusion criteria was dominated by parenting interventions. This 
meant that our analysis says little specifically about the value of child- or teacher-focused 
interventions.  Eighth, in a related manner no trials included measures of changes in adult 
responses to children with ADHD other than parents. Finally, we decided not to conduct or 
report an analysis of publication bias using techniques such as funnel plots because their 
interpretation is equivocal when based on a small number of studies – with difficulty in 
particular distinguishing between the effects of study heterogeneity and publication bias with 
sparse data 
36. 
    In summary, while more evidence is required before behavioral interventions can be 
supported as a front-line treatment for core ADHD symptoms, we found evidence that they 
do have beneficial effects on parenting and parents’ sense of empowerment as well as 
independently corroborated effects on conduct problems in children with ADHD. Initial 
evidence from proximal outcomes relating to academic achievement and social skills needs 
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to be confirmed by probably blinded analyses and greater exploration is needed on the 
moderating impact of child age on intervention outcome.  
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  Trial    Treatment   Control  Jadad 
rating 
Sample 
size 
Age 
range 
Sex  Medicated 
For ADHD  
  Delivery  Type      T   C  years  % 
male 
% 
Abikoff (2012) 
34  parent & 
teacher  
behavioral 
training 
 
wait list  2  61  33  8 - 11  69  36 
Antshel (2003)
43 
child & 
parent 
social skills 
training 
wait list  2  80  40  8 - 12  75  93 
Bloomquist (1991
)44   child, 
parent & 
teacher  
cbt  wait list  2  20  16  8.58 
mean 
69  0 in analysis 
Bor (2002)
 24  parent   behavioral training  wait list  3  26  37  3.6 
mean) 
73  0 
Brown (1986)
 45  child   self-control 
training 
attention 
control 
2  10  8  5–13  85  0 
Chacko  (2009)
46   parent   behavioral training  wait list  2  40   40   5-12   73   38.75  
Evans (2011)
 47  parent & 
child  
behavioral and 
social skills 
training 
tau  1  31  18  11-13  71  57 
Fabiano (2010)
48   children  daily report card  tau  2  33  30  6-12  86  52 
Fabiano (2012) 
49  parent  behavioral 
training 
wait list  2  27  28  6 -12  87  54 
Fehlings (1991)
 50  parent & 
child  
cbt  Attention 
control 
2  13  13  8-11  100  0 
Hoath (2002)
 51  parent   behavioral 
training 
wait list  1  9  11  5-9  76  70 
Horn (1991)
 52  parent & 
child  
behavioral & self-
control training 
placebo  2  16  16  7-11   no 
info 
0 
Jones (2008)
 53  parent   behavioral 
training 
wait list  3  50  29  3.8 
mean 
68  0 
Kapalka (2005) 
54  parent  behavioral 
training 
wait list  0  45  41  5 - 10  100  no info 
Langberg (2008)
55  child  & 
parent 
organizational 
skills training 
wait list  1  24  13  Grade 
4 - 7 
83  43 
Langberg (2012)
35  child  & 
parent 
organizational 
skills training 
wait list  2  23  24  Grade 
6 - 8 
74  66 
Mikami (2011)
56   parent  parent coaching 
on social skills 
wait list  2  32  30  6-10  68  64.5 
Molina (2008) 
57  child  & 
parent 
organizational 
skills training 
community   2  11  9  Grade 
6 - 8 
75  31 
MTA (1999;2000 ;2006).  
40, 41, 42 
child, 
parent & 
teacher  
multi-component 
home, school and 
camp 
tau  4  144  146  8.33 
mean  
80  47 
Pfiffner (1997)
33  child & 
parent  
behavioral training 
& cbt 
wait list  2  9  9  8 - 10  72  44 
Pfiffner (2007)
58  child & 
parent  
behavioral training 
& cbt 
wait list  2  36  33  7 - 11  66  3 
Pisterman (1989) 
59  parent  behavioral training  wait list  3  23  23  4.1 
mean 
80  11 
Pisterman (1992)
 60  parent   behavioral training  wait list  3  23  22  4.1 
mean  
91  9 
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Notes : cbt = Cognitive behavioral therapy ; tau = treatment as usual ; no info =  no information provided in the 
paper ; grade =  school year. 
 
 
 
 
 
   
Power (2012)
 61  child, 
& parent,   
behavioral  & 
academic skills 
training  
attention 
 
2  100  99  Grade 
2 - 6 
68  43 
Sonuga-Barke (2001)
 62  parent   behavioral training  counseling  3  30  28  2–4   62  0 
Sonuga-Barke (2004)
 63  parent   behavioral training  wait list  2  59  30  2-4  no 
info 
0 
Thompson (2009)
 64  parent   behavioral training  wait list  4  21  20  2–6   73  0 
Tracey (2005) 
65  parent  stress 
mangement 
wait list  2  20  20  6 - 15  88  88 
V d Hoofdakker (2007)
 66  parent   behavioral training  tau  2  48  48  4-12  76  40 
Webster-Stratton (2011) 
25 
parent & 
child  
behavioral training  wait list  3  49  50  6.4 
mean 
75  13 
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Table 2: Measures used in each trial for the different outcomes 
    CHILD  PARENT 
    ADHD  CP  SS  AS  MH  SC  PP  NP 
Abikoff 
34  MPROX        APRS
1-P        COSS
2-P 
PBLIND                 
Antshel 
43  MPROX      SSRS
3-P           
PBLIND                 
Bloomquist
4
41 
MPROX  CTRS
4-T    SSCS 
A
5-P 
         
PBLIND                 
Bor
24   MPROX  ECBI
6-P  ECBI
6-P      DASS
7-P  PSOC
8-P    PS
9-P 
PBLIND    FOSR
10-
OBS 
          FOSR
10-
OBS 
Brown
45  MPROX  CPRS
11=P  ACTeRS
12
-T 
ACTeRS
12-T 
WRAT
13-
TEST 
       
PBLIND  ACRS
14-T               
Chacko
46    MPROX  DBD 
15-P   DBD 
15-P   IRS 
16-P    BDI
17-P     DPICS
18
OBS 
DPICS 
18OBS 
PBLIND              DPICS 
18 
OBS 
DPICS
18 
OBS 
Evans
47  MPROX   
ADHDRS
1
9-P 
  IRS
16-T  IRS
16-T         
PBLIND                 
Fabiano 
48  MPROX  DBD
15-T   DBD
15-T      APRS
1-P         
PBLIND                 
Fabiano
49  MPROX    ECBI
6-P          DPICS
18-
OBS 
DPICS
18-
OBS 
PBLIND              DPICS
18-
OBS 
DPICS
18-
OBS 
Fehlings
450  MPROX  WWAS
20-P               
PBLIND                   
Hoath
51  MPROX  CAPS
21-P  ECBI
6-P      DASS
7-P  PSBC
22-
P 
  PS
9-P 
PBLIND  CAPS
21-T  SESBI
23-T             
Horn
452  MPROX  CPRS
11-P               
PBLIND                 
Jones
53  MPROX  CPRS
11-P                 
PBLIND                 
Kapalka
54  MPROX    SSQ 
24-T             
PBLIND                 
Langberg
55   MPROX         APRS
1-P         
PBLIND                 
Langberg
35   MPROX  VADPRS
25
-P 
    HPC
26-P        COSS
2-P 
PBLIND 
     
         
Mikami 
56  MPROX     
SSRS
3-P 
     
PBIPC 
27 
obs 
PBIPC 
27 
obs 
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26 
27 
28 
29 
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31 
32 
33 
34 
35 
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39 
40 
41 
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57 
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59 
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  PBLIND 
     
     
PBIPC 
27 
obs 
PBIPC 
27 
obs 
 
Molina
57  MPROX    ACPS
28P    Sch   
grad
29 
       
PBLIND                 
MTA
40,41,42  MPROX  SNAP
30-P   SNAP
30-P    WIAT
31-
test 
BDI
17-P    PCRQ
32-
P 
PCRQ
32-P 
PBLIND  Classob
33-
OBS 
Classob
33-
OBS 
        OBS
34   
Pfiffner
33   MPROX      SSRS
3-P           
PBLIND                 
Pfiffner
58   MPROX      SSRS
3-P           
PBLIND                 
Pisterman
59   MPROX     clinob
35-
OBS  
        clinob
35-
OBS 
clinob
35-
OBS 
PBLIND    clinob
35-OBS          clinob
35-
OBS 
clinob
35-
OBS 
Pisterman
60   MPROX  clinob
35-OBS  clinob
35-OBS          clinob
35-
OBS 
clinob
35-
OBS 
PBLIND  clinob
35-OBS  clinob
35-OBS          clinob
35-
OBS 
clinob
35-
OBS 
Power
61   MPROX  SNAP
30-P  SNAP
30-P    APRS
1-T    PES
36-P  PCRQ
32-
P 
PCRQ
32-P 
PBLIND                 
Sonuga-
Barke 
62 
MPROX  PACS
37-P  PACS
37-P      GHQ
38-P  PSOC
8-P     
PBLIND  homeob
39-
obs 
             
Sonuga-
Barke 
63 
MPROX  PACS
37        GHQ
38-P  PSOC
8-P     
PBLIND                 
Thompson
64   MPROX  PACS
37   PACS
37       GHQ
38-P    GIPCI
40-
OBS 
EE
39-
SPEECH 
PBLIND  homeob
39-
OBS 
GIPCI
40-
OBS 
        GIPCI
40-
OBS 
EE
39-
SPEECH 
Tracey
65  MPROX          BDI
17-P  PLOC
42-
P 
  PS
9-P 
PBLIND                 
Van den 
Hoofdakkar
6
6 
MPROX  CPRS
11-P        PSI
43-p  PSI
43-p     
PBLIND                 
Webster-
Stratton 
25 
MPROX  CPRS
11-P   CPRS
11-P  SCS
44-P        PPI 
45-P  PPI
43-P 
PBLIND  COCA-R
46            DPICS
18-
OBS 
DPICS
17-
OBS 
DPICS
17-
OBS 
 
Note: MPROX=most proximal rating; PBLIND=probably blinded rating. ADHD Attention Deficit Hyperactivity Disorder,; CP 
conduct problems; SS social skills; AS academic skills; MH mental health; SC self concept; PP positive parenting; NP negative 
parenting;  Superscript letter codes who provided the assessment. 
P=parent; 
T=teacher; 
OBS=observation; 
SPEECH=speech 
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sample; 
TEST=academic skills test. Superscript number gives full name of test; 
1 Academic Performance Rating Scale 
2 
Children‘s Organizational Skills Scale 
3 Social Skills Rating Scale 
4 Conners Teachers Rating Scale 
5 Walker-McConnel Scale of 
Social Competence and School Adjustment 
6 Eyberg Child Behavior Inventory 
7 Depression Anxiety and Stress Scale 
8 
Parenting Sense of Competence Scale 
9 Parenting Scale 
10 Family Observation Schedule 
11 Conners Parent Rating Scale – 
Hyperactivity 
12  ACTeRS ADD-H Comprehensive Teachers Rating Scale 
13 Wide Range Achievement Test 
14Abbreviated 
Conners Rating Scale 
15  Disruptive Disorders Rating Scale 
16 Impairment Rating Scale  
17 Beck Depression Inventory 
18 Dyadic 
Parent-child Interaction Coding System 
19 Attention Deficit Hyperactivity Disorder Rating Scale
20 Werry Weiss Activity Scale 
21 
Child Attention Problem Rating Scale 
22 Problem Setting and Behavior Checklist 
23 Sutter-Eyberg Student Behavior Inventory 
Revised. 
24 Social Situations Questionnaire 
24 APRS  
25 Vanderbilt ADHD Diagnostic  Parent Rating Scale  
26 Homework 
Problem Checklist 
27 Parental Behavior in Parent-Child Interaction. 
28 Aggression and Conduct Problem Scale 
29School Grade 
Records 
30  Pelham Swanson and Nolan Questionnaire 
31 Wechsler Individual Achievement Test 
32 Parent Child Relationship 
Questionnaire 
33 Classroom Observation 
34 Observed constructive
 parenting 
35Clinic Observation 
36 Parent as Educator 
37 
Parent Account of Childhood Symptoms Interview 
38 General Health Questionnaire  
39 Home observation of on task behaviour 
40 
Global Impressions of Parent Child Interaction Revised  
41  Expressed Emotion measured using the Pre-school Five Minute 
Speech Sample 
42 Parents Locus of Control  
43 Parenting Stress Inventory 
44 Social Competence Scale 
45 Parenting Practices 
Inventory. 
46 Coder Observation of Classroom Adaption-Revised: Cognitive Concentration. 
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Figure 1: Flow chart showing the selection of trials. See supplementary information for  
specific reasons for exclusion 
 
 
Figure 2: Parental outcomes 
 
Figure 2: Child outcomes 
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